Cerebrospinal fluid biomarkers for early and differential Alzheimer's disease diagnosis

M Bjerke, S Engelborghs - Journal of Alzheimer's Disease, 2018 - content.iospress.com
An accurate and early diagnosis of Alzheimer's disease (AD) is important to select optimal
patient care and is critical in current clinical trials targeting core AD neuropathological …

Update on vascular cognitive impairment associated with subcortical small-vessel disease

A Wallin, GC Román, M Esiri… - Journal of …, 2018 - content.iospress.com
Subcortical small-vessel disease (SSVD) is a disorder well characterized from the clinical,
imaging, and neuropathological viewpoints. SSVD is considered the most prevalent …

Progress toward standardized diagnosis of vascular cognitive impairment: guidelines from the vascular impairment of cognition classification consensus study

OA Skrobot, SE Black, C Chen, C DeCarli… - Alzheimer's & …, 2018 - Wiley Online Library
Introduction Progress in understanding and management of vascular cognitive impairment
(VCI) has been hampered by lack of consensus on diagnosis, reflecting the use of multiple …

[图书][B] Psicopatologia e semiologia dos transtornos mentais

P Dalgalarrondo - 2018 - books.google.com
Page 1 Atualizado de acordo com O DSM-5 e a CID-11 Paulo Dalgalarrondo PSICO patologia
e Semiologia dOs TranstOrnOs Mentais Page 2 Aviso Todo esforço foi feito para garantir a …

The vascular impairment of cognition classification consensus study

OA Skrobot, J O'Brien, S Black, C Chen… - Alzheimer's & …, 2017 - Wiley Online Library
Introduction Numerous diagnostic criteria have tried to tackle the variability in clinical
manifestations and problematic diagnosis of vascular cognitive impairment (VCI) but none …

EEG and cognitive biomarkers based mild cognitive impairment diagnosis

N Sharma, MH Kolekar, K Jha, Y Kumar - Irbm, 2019 - Elsevier
Abstract Objective Recently, Electroencephalogram (EEG) shows potential in the diagnosis
of Alzheimer's disease and other dementia. We aim to investigate whether EEG and …

Peri-infarct upregulation of the oxytocin receptor in vascular dementia

EC McKay, JS Beck, SK Khoo… - … of Neuropathology & …, 2019 - academic.oup.com
Vascular dementia (VaD) is cognitive decline linked to reduced cerebral blood perfusion, yet
there are few therapeutic options to protect cognitive function following cerebrovascular …

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

I Bos, S Vos, R Vandenberghe, P Scheltens… - Alzheimer's research & …, 2018 - Springer
Background There is an urgent need for novel, noninvasive biomarkers to diagnose
Alzheimer's disease (AD) in the predementia stages and to predict the rate of decline …

Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease-A consensus report

A Wallin, E Kapaki, M Boban, S Engelborghs… - BMC neurology, 2017 - Springer
Background Vascular cognitive impairment (VCI) is a heterogeneous entity with multiple
aetiologies, all linked to underlying vascular disease. Among these, VCI related to …

The full spectrum of Alzheimer's disease is rooted in metabolic derangements that drive type 3 diabetes

SM de la Monte - Diabetes Mellitus: A risk factor for Alzheimer's Disease, 2019 - Springer
The standard practice in neuropathology is to diagnose Alzheimer's disease (AD) based on
the distribution and abundance of neurofibrillary tangles and Aβ deposits. However, other …